
Itamar Medical Ltd. ITMR
Itamar Medical Ltd. Deferred Revenue 2011-2026 | ITMR
Deferred revenue is the amount of money or obligations that a company has received in advance for goods or services that have not yet been delivered or performed. In other words, it is income that has already been received but has not yet been recognized in accounting as revenue because the goods or services have not yet been transferred to the customer.Features of the metric
- Sources of future cash inflows
A high level of deferred revenue indicates that the company has secured future cash flows, which positively affects forecasts of its financial condition and stability. - Assessment of operational stability
Deferred revenue reflects demand for the company’s products or services and its ability to attract customers willing to pay in advance. It is one of the indicators of business stability and its competitive advantages. - Risks and obligations
Although deferred revenue indicates future inflows, it also represents obligations that the company must fulfill. If fulfilling these obligations is delayed or impossible, it can negatively impact reputation and financial results. - Analysis of liquidity and cash flow
Inflows in the form of deferred revenue improve the company’s current liquidity since the funds are already in the accounts. However, investors need to assess the ratio of deferred revenue to fulfilled obligations to understand the actual financial capabilities and risks. - Impact on company valuation
In fundamental analysis, deferred revenue is taken into account for accurate revenue and profit forecasting, especially in industries with long-term contracts or subscriptions (e.g., IT sector, services, manufacturing).
Annual Deferred Revenue Itamar Medical Ltd.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 732 K | 1.03 M | 255 K | 193 K | 158 K | 200 K | 95 K | 84 K | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.03 M | 84 K | 344 K |
Deferred Revenue of other stocks in the Medical devices industry
| Issuer | Deferred Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
508 K | - | - | $ 1.77 B | ||
|
Helius Medical Technologies
HSDT
|
148 K | $ 1.99 | -7.87 % | $ 1.21 M | ||
|
Aziyo Biologics
AZYO
|
533 K | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
401 K | - | -26.83 % | $ 2.62 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
10.5 M | $ 9.37 | -1.94 % | $ 722 M | ||
|
BioSig Technologies
BSGM
|
16 K | - | 37.08 % | $ 85.7 M | ||
|
Inogen
INGN
|
5.48 M | $ 6.51 | 1.32 % | $ 173 M | ||
|
Allied Healthcare Products
AHPI
|
563 K | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
424 K | - | -5.86 % | $ 30.6 M | ||
|
IRIDEX Corporation
IRIX
|
2.4 M | $ 1.32 | -0.38 % | $ 21.3 M | ||
|
IRadimed Corporation
IRMD
|
2.87 M | $ 99.1 | -2.63 % | $ 1.26 B | ||
|
LENSAR
LNSR
|
1.68 M | $ 5.55 | -0.63 % | $ 63.9 M | ||
|
Conformis
CFMS
|
215 K | - | - | $ 16.4 M | ||
|
Delcath Systems
DCTH
|
170 K | $ 9.08 | -1.3 % | $ 325 M | ||
|
Medtronic PLC
MDT
|
315 M | $ 87.7 | -0.2 % | $ 113 B | ||
|
Dynatronics Corporation
DYNT
|
150 K | - | 14.99 % | $ 929 K | ||
|
Cardiovascular Systems
CSII
|
2.11 M | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
335 K | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
88 K | - | - | $ 475 M | ||
|
CryoLife, Inc.
CRY
|
1.45 M | - | -4.14 % | $ 702 M | ||
|
Outset Medical
OM
|
13.8 M | $ 3.48 | -1.56 % | $ 52.9 K | ||
|
Insulet Corporation
PODD
|
14 M | $ 219.0 | 1.39 % | $ 15.4 B | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
33 | - | -1.98 % | $ 98.3 M | ||
|
Quanterix Corporation
QTRX
|
20.7 M | $ 3.95 | -0.25 % | $ 168 M | ||
|
Misonix, Inc.
MSON
|
13.3 K | - | - | $ 462 M | ||
|
Intersect ENT, Inc.
XENT
|
137 K | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
419 K | $ 0.62 | -8.01 % | $ 33.7 M | ||
|
Aethlon Medical
AEMD
|
345 K | $ 2.33 | 0.43 % | $ 3.64 M | ||
|
Sintx Technologies
SINT
|
4.72 K | $ 2.42 | -5.47 % | $ 6.71 M | ||
|
BIOLASE
BIOL
|
2.45 M | - | -13.19 % | $ 166 K | ||
|
LivaNova PLC
LIVN
|
11.5 M | $ 63.79 | 0.77 % | $ 3.48 B | ||
|
InspireMD
NSPR
|
20 K | $ 1.73 | -1.14 % | $ 111 M | ||
|
Sensus Healthcare
SRTS
|
842 K | $ 4.05 | -4.03 % | $ 66.1 M | ||
|
AdaptHealth Corp.
AHCO
|
59.8 M | $ 11.45 | 0.48 % | $ 1.55 B | ||
|
Penumbra
PEN
|
9.16 M | $ 336.8 | 0.16 % | $ 13.1 B | ||
|
Invacare Corporation
IVC
|
2.28 M | - | - | $ 24.7 M | ||
|
Myomo
MYO
|
2.51 K | $ 0.68 | -2.24 % | $ 28.5 M |